In another aspect, the present invention features a human anti L 15 antibody conjugated to {HEAD ~ a therapeutic moiety}, e.g., a cytotoxic drug, an enzymatically active toxin, or a fragment thereof, a radioisotope, or {TAIL ~ a small molecule anti cancer drug} 
In another aspect , the present invention features a human anti L 15 antibody conjugated to { HEAD ~ a therapeutic moiety } , e.g. , a cytotoxic drug , an enzymatically active toxin , or a fragment thereof , a radioisotope , or { TAIL ~ a small molecule anti cancer drug }
OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH HEAD HEAD HEAD HEAD HEAD HEAD HEAD OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH TAIL TAIL TAIL TAIL TAIL TAIL TAIL TAIL TAIL TAIL